- Home
- QMCO vs BCAB Comparison
QMCO vs BCAB Comparison
Compare QMCO & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QMCO
- BCAB
- Stock Information
- Founded
- QMCO 1980
- BCAB 2007
- Country
- QMCO United States
- BCAB United States
- Employees
- QMCO N/A
- BCAB N/A
- Industry
- QMCO Electronic Components
- BCAB Medicinal Chemicals and Botanical Products
- Sector
- QMCO Technology
- BCAB Health Care
- Exchange
- QMCO Nasdaq
- BCAB Nasdaq
- Market Cap
- QMCO 83.2M
- BCAB 77.8M
- IPO Year
- QMCO N/A
- BCAB 2020
- Fundamental
- Price
- QMCO $53.81
- BCAB $1.29
- Analyst Decision
- QMCO Hold
- BCAB Buy
- Analyst Count
- QMCO 2
- BCAB 2
- Target Price
- QMCO $5.00
- BCAB $5.00
- AVG Volume (30 Days)
- QMCO 6.2M
- BCAB 645.3K
- Earning Date
- QMCO 12-24-2024
- BCAB 11-07-2024
- Dividend Yield
- QMCO N/A
- BCAB N/A
- EPS Growth
- QMCO N/A
- BCAB N/A
- EPS
- QMCO N/A
- BCAB N/A
- Revenue
- QMCO $285,238,000.00
- BCAB $11,000,000.00
- Revenue This Year
- QMCO N/A
- BCAB N/A
- Revenue Next Year
- QMCO N/A
- BCAB N/A
- P/E Ratio
- QMCO N/A
- BCAB N/A
- Revenue Growth
- QMCO N/A
- BCAB N/A
- 52 Week Low
- QMCO $2.22
- BCAB $1.14
- 52 Week High
- QMCO $33.00
- BCAB $4.02
- Technical
- Relative Strength Index (RSI)
- QMCO 71.54
- BCAB 33.19
- Support Level
- QMCO $16.62
- BCAB $1.28
- Resistance Level
- QMCO $31.00
- BCAB $1.72
- Average True Range (ATR)
- QMCO 4.66
- BCAB 0.10
- MACD
- QMCO 0.74
- BCAB -0.02
- Stochastic Oscillator
- QMCO 69.10
- BCAB 4.35
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.